Ibutop (Ibuprofen)

Ibuprofen in Ibutop reversibly blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels in the skin and underlying tissues, the drug diminishes the inflammatory response, thereby reducing pain and swelling at the site of application.

The specific amount and frequency of Ibutop application are determined by the prescribing healthcare professional. Typically, a thin layer is spread over the affected area no more than three to four times daily, but the exact regimen should follow the prescriber’s instructions.

Safety data for topical ibuprofen during pregnancy and lactation are limited. Healthcare providers usually advise caution and may recommend alternative therapies, especially in the first trimester or while breastfeeding, to avoid any potential risk to the fetus or infant.

To request Ibutop, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibutop contains ibuprofen, which offers a well‑documented safety profile and effective analgesic action. Compared with other topical NSAIDs such as diclofenac gel, ibuprofen may provide similar pain relief with a slightly different skin‑penetration profile, and it is available over the counter in many EU markets.

Ibutop should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and ensure it is out of reach of children.

Apply a thin layer of Ibutop to clean, dry skin over the painful area. Gently massage until the product is absorbed. Wash your hands after application unless the hands are the treatment site, and avoid covering the area with occlusive dressings unless directed by a clinician.

Serious risks, though rare, include severe allergic skin reactions such as Stevens‑Johnson syndrome, systemic effects like gastrointestinal upset, renal impairment, or liver enzyme changes if significant systemic absorption occurs. Prompt medical attention is required if any of these symptoms develop.

Ibutop should be avoided by individuals with known hypersensitivity to ibuprofen or any component of the formulation, those with open wounds or infected skin at the intended site, and patients taking systemic anticoagulants or other NSAIDs without medical guidance.